350 related articles for article (PubMed ID: 8608665)
41. [Cardioprotective effect of erythropoietin preparations in patients with chronic renal failure].
Nikolaev AIu; Ermolenko VM; Milovanova LIu; Milovanov IuS
Ter Arkh; 2004; 76(9):40-3. PubMed ID: 15532375
[TBL] [Abstract][Full Text] [Related]
42. Erythropoietin and renal anemia.
Hörl WH
Biotechnol Ther; 1991; 2(3-4):213-30. PubMed ID: 1845127
[TBL] [Abstract][Full Text] [Related]
43. Evidence that treatment of ESRD patients with recombinant human erythropoietin induces immunosuppression without affecting the distribution of peripheral blood mononuclear cell subpopulations.
Steffensen G; Aunsholt NA; Povlsen JV
Clin Nephrol; 1996 Feb; 45(2):98-103. PubMed ID: 8846537
[TBL] [Abstract][Full Text] [Related]
44. [Recombinant erythropoietin (r-HuEPO) in the treatment of anemia in multiple myeloma].
Spicka I; Haber J; Petruzelka L; Kolesková E; Sálková J; Straub J; Zounar R; Klener P
Cas Lek Cesk; 1996 Jul; 135(14):450-3. PubMed ID: 8925545
[TBL] [Abstract][Full Text] [Related]
45. Seizures in haemodialysis patients treated with recombinant human erythropoietin.
Edmunds ME; Walls J; Tucker B; Baker LR; Tomson CR; Ward M; Cunningham J; Moore R; Winearls CG
Nephrol Dial Transplant; 1989; 4(12):1065-9. PubMed ID: 2517327
[TBL] [Abstract][Full Text] [Related]
46. Chronic occult intra-alveolar hemorrhage: a rare cause of failure to respond to erythropoietin.
Conlon PJ; O'Neill S; O'Neill G; Kelly F; Donohoe J
Clin Nephrol; 1994 Feb; 41(2):83-5. PubMed ID: 8004833
[TBL] [Abstract][Full Text] [Related]
47. Adverse effects of therapy for the correction of anemia in hemodialysis patients.
Watson AJ
Semin Nephrol; 1989 Mar; 9(1 Suppl 1):30-4. PubMed ID: 2648519
[TBL] [Abstract][Full Text] [Related]
48. Does early anemia correction prevent complications of chronic renal failure?
Drüeke TB; Eckardt KU; Frei U; Jacobs C; Kokot F; McMahon LP; Schaefer RM
Clin Nephrol; 1999 Jan; 51(1):1-11. PubMed ID: 9988140
[TBL] [Abstract][Full Text] [Related]
49. Changes of enzyme activity levels in red blood cells in hemodialysis patients by recombinant human erythropoietin.
Suzuki Y; Ogura Y; Otsubo O; Mimura N; Takaku F; Maeda T
Nihon Jinzo Gakkai Shi; 1992 Sep; 34(9):1019-23. PubMed ID: 1479730
[TBL] [Abstract][Full Text] [Related]
50. [Recombinant human erythropoietin in the treatment of anemic patients undergoing chemotherapy for cancer].
Bösze P; Mayer A; Thurzó L; Kiss A; Rák K; Stumpf J
Orv Hetil; 1995 Nov; 136(47):2567-72. PubMed ID: 8532322
[TBL] [Abstract][Full Text] [Related]
51. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.
Roth D; Smith RD; Schulman G; Steinman TI; Hatch FE; Rudnick MR; Sloand JA; Freedman BI; Williams WW; Shadur CA
Am J Kidney Dis; 1994 Nov; 24(5):777-84. PubMed ID: 7977319
[TBL] [Abstract][Full Text] [Related]
52. Anemia, hypertension, and myocardial dysfunction in end-stage renal disease.
Venkatesan J; Henrich WL
Semin Nephrol; 1997 Jul; 17(4):257-69. PubMed ID: 9241712
[TBL] [Abstract][Full Text] [Related]
53. Effect of erythropoietin therapy on red cells filterability and left ventricular mass in predialysis patients.
Hassan K; Roguin N; Kaganov Y; Hasan S; Kristal B
Ren Fail; 2005; 27(2):177-82. PubMed ID: 15807182
[TBL] [Abstract][Full Text] [Related]
54. Recombinant human erythropoietin: impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life.
Nissenson AR
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):25-31. PubMed ID: 2669083
[TBL] [Abstract][Full Text] [Related]
55. Utilization of erythropoietin in the treatment of the anemia due to chronic renal failure.
Drüeke T; Zins B; Naret C; Casadevall N; Goureau Y; Bererhi L; Peterlongo F; Castaigne JP; Zingraff J; Delons S
Adv Nephrol Necker Hosp; 1989; 18():187-206. PubMed ID: 2493715
[TBL] [Abstract][Full Text] [Related]
56. Clinical effect of recombinant human erythropoietin on anemia associated with chronic renal failure. A multi-institutional study in Japan.
Akizawa T; Koshikawa S; Takaku F; Urabe A; Akiyama N; Mimura N; Otsubo O; Nihei H; Suzuki Y; Kawaguchi Y
Int J Artif Organs; 1988 Sep; 11(5):343-50. PubMed ID: 3056862
[TBL] [Abstract][Full Text] [Related]
57. [Erythropoietin--the first hematologic hormone in clinical use].
Rhyner K
Schweiz Med Wochenschr; 1988 Mar; 118(11):375-80. PubMed ID: 3287601
[TBL] [Abstract][Full Text] [Related]
58. [Erythropoietin, a milestone in the history of nephrology].
Uehlinger DE; Frey FJ
Ther Umsch; 1995 Oct; 52(10):672-7. PubMed ID: 7482378
[TBL] [Abstract][Full Text] [Related]
59. Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients.
Abraham PA; Opsahl JA; Rachael KM; Asinger R; Halstenson CE
Am J Nephrol; 1990; 10(2):128-36. PubMed ID: 2349956
[TBL] [Abstract][Full Text] [Related]
60. Erythropoietin use in pregnancy: two cases and a review of the literature.
Scott LL; Ramin SM; Richey M; Hanson J; Gilstrap LC
Am J Perinatol; 1995 Jan; 12(1):22-4. PubMed ID: 7710570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
